Circulating cytokine dynamics as potential biomarker of response to anti-PD-1 immunotherapy in BRAFwt MM patients

Background: The biomarkers of immune checkpoint inhibitors (ICIs) efficacy and safety are still urgently needed. As cytokines are easily detected and monitored in circulation, they could be used as potential predictors of response and immune-related adverse events (irAEs) for ICIs therapy. Methods:...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Katarina Mirjačić Martinović, Ana Vuletić, Nevena Tišma Miletić, Irina Besu Žižak, Jelena Milovanović, Suzana Matković, Vladimir Jurišić
التنسيق: مقال
اللغة:English
منشور في: Elsevier 2023-12-01
سلاسل:Translational Oncology
الموضوعات:
الوصول للمادة أونلاين:http://www.sciencedirect.com/science/article/pii/S1936523323001857